Currently out of the existing stock ratings of Ashwani Verma, 131 are a BUY (72.38%), 44 are a HOLD (24.31%), 6 are a SELL (3.31%).

Ashwani Verma

Work Performance Price Targets & Ratings Chart

Analyst Ashwani Verma, currently employed at UBS, has had 61.68% of price targets met with an average potential upside of 27.05%, reached in 168 days on average.

Ashwani Verma has documented 362 price targets and ratings displayed on 30 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on AXSM, Axsome Therapeutics at 02-Nov-2026.

Wall Street Analyst Ashwani Verma

Analyst best performing recommendations are on CRNX (CRINETICS PHARMACEUTICALS).
The best stock recommendation documented was for CRNX (CRINETICS PHARMACEUTICALS) on 7/2/2026. The price target of $55 was fulfilled within 5 days with a profit of $12.77 (30.24%), with a performance score of 60.48.

Average potential price target upside

ITCI Intracellular Th HZNP Horizon Pharma PLC CHRS Coherus BioSciences JAZZ Jazz Pharmaceuticals PLC RPRX Royalty Pharma Plc TEVA Teva Pharma Industries Ltd ADR VTRS Viatris CYTK Cytokinetics KRTX Karuna Therapeutics NBIX Neurocrine Biosciences UTHR United Therapeutics ALKS Alkermes Plc AXSM Axsome Therapeutics RANI Rani Therapeutics Holdings ACAD ACADIA Pharmaceuticals ACLX Arcellx AVDL Avadel Pharmaceuticals PLC BHVN Biohaven Pharmaceutical Holding Co Ltd EXEL Exelixis LEGN Legend Biotech Corp HRMY Harmony Biosciences Holdings BIIB Biogen INCY yte INSM Insmed ALVO Alvotech IT Gartner RCKT Rocket Pharmaceuticals AMRX Amneal Pharmaceuticals CORT Corcept Therapeutics CRNX Crinetics Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 02-Apr-2025

$132

$132

1 years 7 months 17 days ago
(02-Apr-2025)

26/28 (92.86%)

$0.13 (0.10%)

512

Hold Since 28-Feb-2025

$132

$132

1 years 8 months 22 days ago
(28-Feb-2025)

12/14 (85.71%)

$3.8 (2.96%)

738

Buy Since 10-Dec-2020

$132

$140

1 years 8 months 26 days ago
(24-Feb-2025)

14/16 (87.5%)

$3.43 (2.67%)

274

Hold Since 21-Feb-2025

$100

1 years 8 months 29 days ago
(21-Feb-2025)

24/25 (96%)

$-27.19 (-21.38%)

152

Hold Since 08-Aug-2024

$132

$87

1 years 9 months 14 days ago
(05-Feb-2025)

7/8 (87.5%)

$4.97 (3.91%)

209

Show more analysts

Please expand the browser size to see the chart

Which stock is Ashwani Verma most bullish on?

Potential upside of $94.63 has been obtained for AXSM (AXSOME THERAPEUTICS)

Which stock is Ashwani Verma most reserved on?

Potential downside of -$17.84 has been obtained for EXEL (EXELIXIS)

What Year was the first public recommendation made by Ashwani Verma?

On 2020
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?